Article
Noninvasive prenatal diagnosis targeting fetal nucleated red blood cells
30 Dec 2022
Abstract excerpt
Noninvasive prenatal diagnosis (NIPD) aims to detect fetal-related genetic disorders before birth by detecting markers in the peripheral blood of pregnant women, holding the potential in reducing the risk of fetal birth defects. Fetal-nucleated red blood cells (fNRBCs) can be used as biomarkers for NIPD, given their remarkable nature of carrying the entire genetic information of the fetus. Here, we review recent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
